avatar

Eric A. Klein, MD

Eric A. Klein, MD, is an international leader in the biology and management of prostate cancer. Dr. Klein serves as Chairman of the Glickman Urological & Kidney Institute.

Do Men Really Need PSA Tests for Prostate Cancer?

The merits of PSA (prostate-specific antigen) testing for prostate cancer have long been debated. Does testing identify too many harmless, slow-growing cancers — or does it save lives? Tap or click to reveal the answer.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Does Your Prostate Cancer Need Treatment?

If you’ve been diagnosed with prostate cancer, don’t assume that surgery or radiation therapy is in your future. First, talk to your doctor about how aggressive your cancer may be. While surgery or radiation is best for some aggressive cancers, it’s not always necessary.

How Doctors Today Are Screening Smarter for Prostate Cancer

Within a few years of using prostate-specific antigen (PSA) tests, we saw an amazing shift: By the mid-1990s, most men newly diagnosed with prostate cancer were curable. Since then, studies have shown that while PSA screening reduces a man’s likelihood of dying from prostate cancer, it does not reduce overall mortality. The problem has been with how we use PSA tests.

Advertising Policy

Medicare Considers Coverage of Genetic Prostate Cancer Test

Overtreatment of prostate cancer represents one of the most significant issues in men’s health today. As a result of the limited information available from a biopsy, more than 90 percent of low-risk patients undergo immediate treatment, such as prostate removal or radiation, despite having less than a 3 percent chance of their low-risk disease progressing to become … Read More